Welcome, Guest
Username: Password: Remember me
Adult Stem Cell News and Developments other than Cytori
  • Page:
  • 1

TOPIC: Baxter giving up on Phase III cardiac trial?

Baxter giving up on Phase III cardiac trial? 27 Dec 2013 09:47 #1160

  • fas
  • fas's Avatar Topic Author
  • Offline
  • Moderator
  • Moderator
  • May the fat be with you
  • Posts: 3357
  • Thank you received: 1116
Bill Busa had this to report- Bill Busa site

The latest record update for Baxter's (BAX) high-profile Phase 3 trial of unexpanded autologous CD34+ stem cells for myocardial ischemia suggests the company is throwing in the towel on this trial. With just two thirds of its anticipated 444 patients recruited, the trial's status has changed from "Recruiting" to "Active, Not Recruiting," all three Canadian sites were deleted, and all 41 U.S. sites' names were expunged. A local newspaper report claims "Baxter has suspended all future candidates to stem cell heart injections for UCLA." This follows the termination/withdrawal from this trial of 4 other sites since August. As of press time the company has issued no discussion.

Not unexpected at all.

Please Log in or Create an account to join the conversation.

Board moderator and Site-owner. I still regret the day I started analysing the prospects of MacroPore (now Cytori) back in 2004- a left-over from the tech-bubble at that time from the century change in my portfolio- and became addicted to Cytori´s fat cell technology. :cry:

Baxter giving up on Phase III cardiac trial? 27 Dec 2013 11:51 #1161

  • myownhedgefund
  • myownhedgefund's Avatar
  • Offline
  • Platinum Boarder
  • Platinum Boarder
  • Posts: 2860
  • Thank you received: 204
Well maybe they will look seriously at what ATHENA 1 and 2 results produce and take a trip to SD.

Writting was on the wall for Baxter for some time.

Please Log in or Create an account to join the conversation.

  • Page:
  • 1
Time to create page: 0.087 seconds

Copyright Information

Copyright Fas Kuiters © 2016 young-foxes.com. All Rights Reserved.
This page is made with Joomla CMS and its various templates designed by Fas Kuiters with the excellent Themler tool.

 

 

Shared Spreadsheet Links

DOV´s Revised Projections for the Periods 2017 until 2020

Shareble link : HERE

Fas Kuiters Websites